The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea

Lee, S. B; Kim, S. K; Kang, T. J; Chee, G. T; Chun, J. H; Shin, H. K; Kim, J.P; Ko, Y. H.
s.l; s.n; 2001. 4 p. ilus, tab.
No convencional en Inglés | SES-SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, SES-SP | ID: biblio-1238528

Documentos relacionados

  1. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
  2. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
  3. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
  4. Novel mutations found in Mycobacterium leprae DNA repair gene nth from central India.
  5. Heterogeneous persistence of Mycobacterium leprae in oral and nasal mucosa of multibacillary patients during multidrug therapy.
  6. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
  7. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
  8. A case report and literature review: Mycobacterium leprae infection diagnosed by metagenomic next-generation sequencing of cerebrospinal fluid.
  9. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
  10. Critical observation of WHO recommended multidrug therapy on the disease leprosy through mathematical study.